Genoway (France) Executives

ALGEN Stock  EUR 2.49  0.04  1.63%   
Discussion of Genoway's management performance can provide insight into the enterprise performance.
Alexandre Fraichard  Chairman
Chairman of the Board and CEO
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Genoway. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Genoway Management Team Effectiveness

The company has return on total asset (ROA) of 0.0136 % which means that it generated a profit of $0.0136 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0712 %, meaning that it generated $0.0712 on every $100 dollars invested by stockholders. Genoway's management efficiency ratios could be used to measure how well Genoway manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/07/2026, Return On Tangible Assets is likely to grow to 0.07. Also, Return On Capital Employed is likely to grow to 0.09. As of 02/07/2026, Total Current Liabilities is likely to drop to about 6.3 M. In addition to that, Liabilities And Stockholders Equity is likely to drop to about 20.6 M
As of 02/07/2026, Net Income Applicable To Common Shares is likely to grow to about 2.2 M, while Common Stock Shares Outstanding is likely to drop slightly above 7.4 M. The market capitalization of Genoway is €30.72 Million. Genoway retains 7.75 (percent) of its outstanding shares held by insiders and 15.78 (percent) owned by outside corporations. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
 
Shares in Circulation  
First Issued
2008-12-31
Previous Quarter
9.8 M
Current Value
9.8 M
Avarage Shares Outstanding
6.5 M
Quarterly Volatility
1.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
As of 02/07/2026, Dividend Paid And Capex Coverage Ratio is likely to drop to 2.46. As of 02/07/2026, Net Income Applicable To Common Shares is likely to grow to about 2.2 M, while Common Stock Shares Outstanding is likely to drop slightly above 7.4 M.

Genoway Workforce Comparison

Genoway is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 160. Genoway adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average.

Genoway Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Genoway Price Series Summation is a cross summation of Genoway price series and its benchmark/peer.

Genoway Stakeholder

Alexandre FraichardChairman of the Board and CEOProfile
String symbol = request.getParameter("s");

About Genoway Management Performance

The success or failure of an entity such as Genoway often depends on how effective the management is. Genoway management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genoway management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genoway management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.06  0.07 
Return On Capital Employed 0.09  0.09 
Return On Assets 0.05  0.05 
Return On Equity 0.11  0.12 

Genoway Workforce Analysis

Traditionally, organizations such as Genoway use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genoway within its industry.

Genoway Manpower Efficiency

Return on Genoway Manpower

Revenue Per Employee22.1M
Net Income Per Employee1.8M
Working Capital Per Employee8.9M

Additional Tools for Genoway Stock Analysis

When running Genoway's price analysis, check to measure Genoway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genoway is operating at the current time. Most of Genoway's value examination focuses on studying past and present price action to predict the probability of Genoway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genoway's price. Additionally, you may evaluate how the addition of Genoway to your portfolios can decrease your overall portfolio volatility.